These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10834450)

  • 1. Association of matrix metalloproteinase expression and left ventricular function in idiopathic dilated cardiomyopathy.
    Yokoseki O; Yazaki Y; Suzuki J; Imamura H; Takenaka H; Isobe M
    Jpn Circ J; 2000 May; 64(5):352-7. PubMed ID: 10834450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.
    Thomas CV; Coker ML; Zellner JL; Handy JR; Crumbley AJ; Spinale FG
    Circulation; 1998 May; 97(17):1708-15. PubMed ID: 9591765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation.
    Rouet-Benzineb P; Buhler JM; Dreyfus P; Delcourt A; Dorent R; Perennec J; Crozatier B; Harf A; Lafuma C
    Eur J Heart Fail; 1999 Dec; 1(4):337-52. PubMed ID: 10937947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationship between MMP-10 and LV remodelling.
    Wei Y; Cui C; Lainscak M; Zhang X; Li J; Huang J; Zhang H; Zheng Z; Hu S
    J Cell Mol Med; 2011 Apr; 15(4):773-82. PubMed ID: 20219015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure.
    Spinale FG; Coker ML; Heung LJ; Bond BR; Gunasinghe HR; Etoh T; Goldberg AT; Zellner JL; Crumbley AJ
    Circulation; 2000 Oct; 102(16):1944-9. PubMed ID: 11034943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of extracellular matrix remodelling are differentially expressed in paediatric and adult dilated cardiomyopathy.
    Hsia TY; Ringewald JM; Stroud RE; Forbus GA; Bradley SM; Chung WK; Spinale FG
    Eur J Heart Fail; 2011 Mar; 13(3):271-7. PubMed ID: 21147820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cardiac mRNA expression of matrix metalloproteinase-1 (MMP-1) and its inhibitor (TIMP-1) in DCM patients.
    Picard F; Brehm M; Fassbach M; Pelzer B; Scheuring S; Küry P; Strauer BE; Schwartzkopff B
    Clin Res Cardiol; 2006 May; 95(5):261-9. PubMed ID: 16598395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices.
    Li YY; Feng Y; McTiernan CF; Pei W; Moravec CS; Wang P; Rosenblum W; Kormos RL; Feldman AM
    Circulation; 2001 Sep; 104(10):1147-52. PubMed ID: 11535571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial remodeling in viral heart disease: possible interactions between inflammatory mediators and MMP-TIMP system.
    Pauschinger M; Chandrasekharan K; Schultheiss HP
    Heart Fail Rev; 2004 Jan; 9(1):21-31. PubMed ID: 14739765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target.
    Spinale FG; Coker ML; Bond BR; Zellner JL
    Cardiovasc Res; 2000 May; 46(2):225-38. PubMed ID: 10773226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoexpression of MMP-8, MMP-9 and TIMP-2 in dilated cardiomyopathy.
    Mitruţ R; Stepan AE; Mărgăritescu C; Andreiana BC; Kesse AM; Simionescu CE; Militaru C
    Rom J Morphol Embryol; 2019; 60(1):119-124. PubMed ID: 31263835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular reverse remodeling is not related to biopsy-detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the definition used for LVRR.
    Rubiś P; Wiśniowska-Śmiałek S; Biernacka-Fijałkowska B; Rudnicka-Sosin L; Wypasek E; Kozanecki A; Dziewięcka E; Faltyn P; Karabinowska A; Khachatryan L; Hlawaty M; Leśniak-Sobelga A; Kostkiewicz M; Płazak W; Podolec P
    Heart Vessels; 2017 Jun; 32(6):714-725. PubMed ID: 28004175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy.
    Schwartzkopff B; Fassbach M; Pelzer B; Brehm M; Strauer BE
    Eur J Heart Fail; 2002 Aug; 4(4):439-4. PubMed ID: 12167381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix Metalloproteinase 2 and 9 Enzymatic Activities are Selectively Increased in the Myocardium of Chronic Chagas Disease Cardiomyopathy Patients: Role of TIMPs.
    Baron MA; Ferreira LRP; Teixeira PC; Moretti AIS; Santos RHB; Frade AF; Kuramoto A; Debbas V; Benvenuti LA; Gaiotto FA; Bacal F; Pomerantzeff P; Chevillard C; Kalil J; Cunha-Neto E
    Front Cell Infect Microbiol; 2022; 12():836242. PubMed ID: 35372112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy.
    Rubiś P; Wiśniowska-Śmialek S; Wypasek E; Biernacka-Fijalkowska B; Rudnicka-Sosin L; Dziewiecka E; Faltyn P; Khachatryan L; Karabinowska A; Kozanecki A; Tomkiewicz-Pająk L; Podolec P
    Inflamm Res; 2016 Dec; 65(12):941-949. PubMed ID: 27516211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
    Peterson JT; Li H; Dillon L; Bryant JW
    Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition.
    Li H; Simon H; Bocan TM; Peterson JT
    Cardiovasc Res; 2000 May; 46(2):298-306. PubMed ID: 10773234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
    Wang W; Zhang HT; Yang XL
    J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):265-9. PubMed ID: 22929563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ; Zhang X; Zhu WL; Huang Y
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP/TIMP profiles.
    Polyakova V; Loeffler I; Hein S; Miyagawa S; Piotrowska I; Dammer S; Risteli J; Schaper J; Kostin S
    Int J Cardiol; 2011 Aug; 151(1):18-33. PubMed ID: 20546954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.